BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26857302)

  • 1. [Effective pain relief of post-herpetic neuralgia with capsaicin patch].
    Andersen HH; Sand C; Elberling J
    Ugeskr Laeger; 2016 Feb; 178(5):V10150846. PubMed ID: 26857302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
    Jones VM; Moore KA; Peterson DM
    J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
    Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M
    Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
    Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
    Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
    Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
    Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
    Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
    BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia.
    Wallace M; Pappagallo M
    Expert Rev Neurother; 2011 Jan; 11(1):15-27. PubMed ID: 21158551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
    Jensen TS; Høye K; Fricová J; Vanelderen P; Ernault E; Siciliano T; Marques S
    Eur J Pain; 2014 Oct; 18(9):1240-7. PubMed ID: 24664539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report.
    Sayanlar J; Guleyupoglu N; Portenoy R; Ashina S
    J Headache Pain; 2012 Oct; 13(7):587-9. PubMed ID: 22717586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
    Burness CB; McCormack PL
    Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
    Wagner T; Poole C; Roth-Daniek A
    Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series.
    Gaul C; Resch S
    Cephalalgia; 2015 May; 35(6):545-50. PubMed ID: 25217483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Irving GA; Backonja MM; Dunteman E; Blonsky ER; Vanhove GF; Lu SP; Tobias J;
    Pain Med; 2011 Jan; 12(1):99-109. PubMed ID: 21087403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal topical capsaicin in post-herpetic neuralgia: a safety pilot study.
    Teixeira MJ; Menezes LM; Silva V; Galhardoni R; Sasson J; Okada M; Duarte KP; Yeng LT; Andrade DC
    Arq Neuropsiquiatr; 2015 Mar; 73(3):237-40. PubMed ID: 25807130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of current guidelines on the care of postherpetic neuralgia.
    Argoff CE
    Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding frontiers in telehealth: Video assisted at-home application of capsaicin 8% patch.
    Shaparin N; Nair S; Vydyanathan A; Hascalovici JR
    Eur J Pain; 2021 Aug; 25(7):1564-1567. PubMed ID: 33759272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports.
    Trbovich M; Yang H
    Am J Phys Med Rehabil; 2015 Aug; 94(8):e66-72. PubMed ID: 26035723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.